NCT05674435

Brief Summary

The aim of the present narrative review is to one of the first to critically evaluate the clinical effectiveness of neuromodulation as a therapeutic option for patients with tinnitus. Our method involves conducting a systemic review and the findings reported following PRISMA statement. Pubmed, Cochrane database and Google Scholar databases literature search was conducted for articles reporting the use of neuromodulatory interventions on tinnitus patients. Each article was evaluated using the Cochrane risk of bias tool.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 30, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 6, 2023

Completed
Last Updated

January 6, 2023

Status Verified

December 1, 2022

Enrollment Period

6 months

First QC Date

December 30, 2022

Last Update Submit

December 30, 2022

Conditions

Tinnitus

Outcome Measures

Primary Outcomes (1)

  • Tinnitus severity scores

    9 months

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Tinnitus patients

You may qualify if:

  • Tinnitus patients
  • At least one of the neurofeedback methods
  • Single and multi-center
  • Randomized control trials and observational studies

You may not qualify if:

  • Non-peer-reviewed papers, letters, editorials
  • Not English language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan

Hsinchu, Taiwan

Location

MeSH Terms

Conditions

Tinnitus

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 30, 2022

First Posted

January 6, 2023

Study Start

January 1, 2022

Primary Completion

June 30, 2022

Study Completion

September 30, 2022

Last Updated

January 6, 2023

Record last verified: 2022-12

Locations

TW(1)